Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Inventory (2016 - 2026)

Apyx Medical filings provide 16 years of Inventory readings, the most recent being $9.8 million for Q4 2025.

  • On a quarterly basis, Inventory rose 29.68% to $9.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $9.8 million, a 29.68% increase, with the full-year FY2025 number at $9.8 million, up 29.68% from a year prior.
  • Inventory hit $9.8 million in Q4 2025 for Apyx Medical, down from $10.3 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $12.0 million in Q3 2022 to a low of $4.5 million in Q1 2021.
  • Median Inventory over the past 5 years was $9.5 million (2022), compared with a mean of $9.0 million.
  • Biggest five-year swings in Inventory: fell 24.0% in 2021 and later soared 99.37% in 2022.
  • Apyx Medical's Inventory stood at $6.8 million in 2021, then skyrocketed by 74.05% to $11.8 million in 2022, then dropped by 15.89% to $9.9 million in 2023, then decreased by 23.77% to $7.6 million in 2024, then grew by 29.68% to $9.8 million in 2025.
  • The last three reported values for Inventory were $9.8 million (Q4 2025), $10.3 million (Q3 2025), and $9.3 million (Q2 2025) per Business Quant data.